Yuchen Bai - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yuchen Bai

Showing results (81-90 of 83) with videos related to

Pageof 9

Sort By:

You have reached the last page of results.This site can display upto 83 results.

Plos One|September 7, 2013

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor modelsAnastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 16, 2011

Osteogenic effects of a potent Src-over-Abl-selective kinase inhibitor in the mouseRichard J Murrills, Shoichi Fukayama, Frank Boschelli, et al.

Cancer Cell|July 16, 2015

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.

Pageof 9

Search research articles

Showing results (81-90 of 83) with videos related to

Sort By:

Pageof 9

You have reached the last page of results.This site can display upto 83 results.

Plos One|September 7, 2013

BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor modelsAnastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.

The Journal of Pharmacology and Experimental Therapeutics|December 16, 2011

Osteogenic effects of a potent Src-over-Abl-selective kinase inhibitor in the mouseRichard J Murrills, Shoichi Fukayama, Frank Boschelli, et al.

Cancer Cell|July 16, 2015

A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P Mohammad, Kimberly N Smitheman, Chandrashekhar D Kamat, et al.

Pageof 9